Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
  1. 4 Grant or award Director acquired 5,208 shares (grant or award)
  2. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,430 shares (grant or award)
  3. 4 Planned sale Director sold 1,775 shares at $9.24 ($16,401)
  4. 4 Open-market sale 10% owner sold 67,114 shares at an average $9.48 ($636,229)
  5. 4 Option exercise Director acquired 4,609 shares (option exercise)
  6. 4 Planned sale Director sold 10,000 shares at $9.78 ($97,800)
  7. 4 Grant or award Director acquired 5,208 shares (grant or award)
  8. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,430 shares (grant or award)
  9. 4 Option exercise Director acquired 36,207 shares (option exercise)
  10. 4 Planned sale Director sold 10,000 shares at $8.92 ($89,200)
  11. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,431 shares (grant or award)
  12. 4 Grant or award Director acquired 5,208 shares (grant or award)
  13. 4 Planned sale Director sold 10,000 shares at $8.09 ($80,900)
  14. 4 Grant or award Director acquired 5,208 shares (grant or award)
  15. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,431 shares (grant or award)
  16. 4 Planned sale Director sold 1,119 shares at $8.71 ($9,746)
  17. 4 Planned sale Director sold 10,000 shares at $8.61 ($86,100)
  18. 4 Grant or award Director acquired 5,208 shares (grant or award)
  19. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,431 shares (grant or award)
  20. 4 Planned sale Director sold 10,000 shares at $7.78 ($77,800)

Page 5 of 18 · 349 filings